heart failure management
Recently Published Documents


TOTAL DOCUMENTS

563
(FIVE YEARS 110)

H-INDEX

35
(FIVE YEARS 4)

BMJ Open ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. e058848
Author(s):  
Tracey McConnell ◽  
John Burden ◽  
Claire Duddy ◽  
Loreena Hill ◽  
Clare Howie ◽  
...  

IntroductionHeart failure affects over 26 million people worldwide with prevalence expected to grow due to an ageing global population. Palliative care can address the holistic needs of patients with heart failure, and integrated palliative care in heart failure management has been indicated to improve outcomes for patients. Despite known benefits for integrated palliative care in heart failure management, implementation is poor across the majority of global health services. Recent systematic reviews have identified the benefits of integrating palliative care into heart failure management and highlighted barriers to implementation. However, there was heterogeneity in terms of countries, healthcare settings, delivery by differing staff across multidisciplinary teams, modes of delivery and different intervention components.Methods and analysisThe aim of this study is to identify how integrated palliative care and heart failure interventions produce desired outcomes, in which contexts, and for which patients. We will undertake a realist synthesis to identify this, using Pawson’s five iterative steps. We will recruit an international stakeholder group comprised of healthcare providers and patients with heart failure to advise and provide feedback throughout the review. Our initial realist programme theory sets out the necessary steps needed to accomplish the final intended outcome(s) from the implementation of integrated palliative care and heart failure. This initial programme theory will be shaped through an iterative process of testing and refinement.Ethics and disseminationEthical approval is not required for this study. With our stakeholder group, we will coproduce a user guide that outlines practical advice to optimise, tailor and implement interventions designed to integrate palliative care and heart failure, taking into consideration local context, alongside user-friendly summaries of the synthesis findings using short animations to convey complex findings. We will draw on the expertise within the stakeholder group to identify key stakeholders for disseminating to relevant audiences, ensuring outputs are tailored for their respective needs.PROSPERO registration numberCRD42021240185.


Author(s):  
Javier de Juan Bagudá ◽  
Juan J. Gavira Gómez ◽  
Marta Pachón Iglesias ◽  
Rocío Cózar León ◽  
Vanessa Escolar Pérez ◽  
...  

Author(s):  
Petar M Seferovic ◽  
Massimo Piepoli ◽  
Marija Polovina ◽  
Ivan Milinkovic ◽  
Giuseppe M C Rosano ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Lucas Burke ◽  
Magdi Hassanin ◽  
Geraldine Ong ◽  
Neil Fam

Concomitant tricuspid regurgitation (TR) is common in patients with mitral regurgitation (MR). While current guidelines recommend repair of both valves at the time of surgery when feasible, high risk patients are often undertreated, leading to significant morbidity and mortality. With advances in transcatheter edge-to-edge repair (TEER) devices and technique, combined TEER for treating significant MR and TR has emerged as a new tool for heart failure management. Recent evidence has shed light on which patients with severe TR should be targeted for transcatheter intervention either in isolation or in combination with a MV TEER procedure and allows for expanded treatment options in patients who otherwise would be limited to medical management. Technological advancements remain ahead of robust clinical data, and thus randomized clinical studies in patients with severe MR and TR will be instrumental in determining the best approach in treating these patients with transcatheter therapies.


Author(s):  
Justin Slade ◽  
Michelle Lee ◽  
Jun Park ◽  
Alexander Liu ◽  
Paul Heidenreich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document